Roles of the ribosomal protein S19 dimer and chemically induced apoptotic cells as a tumor vaccine in syngeneic mouse transplantation models

Journal of Immunotherapy

Volumn 34, Issue 1, 2011, Pages 16-27

  Taniguchi, Keisuke ^a,b   Nishiura, Hiroshi ^a   Ota, Yoshihiko ^a   Yamamoto, Tetsuro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

apoptosis; C5a receptor; find me signal; ribosomal protein S19; tumor immunity

Indexed keywords

CISPLATIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN S19; TUMOR CELL VACCINE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SPLEEN CELL; TUMOR IMMUNITY;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CANCER VACCINES; CELL LINE, TUMOR; CISPLATIN; IMMUNOTHERAPY, ADOPTIVE; IN SITU NICK-END LABELING; INJECTIONS, INTRADERMAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MUTATION; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROTEIN MULTIMERIZATION; RIBOSOMAL PROTEINS; SIGNAL TRANSDUCTION; TRANSPLANTATION, ISOGENEIC;

EID: 78650672325     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3181fb03ed     Document Type: Article

References (26)

1. Nishiura H, Tanase S, Sibuya Y, et al. Determination of the cross-linked residues in homo-dimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity. Lab Invest. 1999;79:915-923.
2. Horino K, Nishiura H, Ohsako T, et al. A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells. Lab Invest. 1998;78:603-617.
3. Nishimura T, Horino K, Nishiura H, et al. Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemo-tactic S19 ribosomal protein dimer. J Biochem. 2001;129: 445-454.
4. Nishiura H, Tanase S, Shibuya Y, et al. S19 ribosomal protein dimer augments metal-induced apoptosis in a mouse fibro-blastic cell line by ligation of the C5a receptor. J Cell Biochem. 2005;94:540-553.
5. Nishiura H, Nonaka H, Revollo IS, et al. Pro- and anti-apoptotic dual functions of the C5a receptor: involvement of regulator of G protein signaling 3 and extracellular signal-regulated kinase. Lab Invest. 2009;89:676-694.
6. Shrestha A, Horino K, Nishiura H, et al. Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection. Lab Invest. 1999;79:1629-1642.
7. Yamamoto T. Roles of the ribosomal protein S19 dimer and the C5a receptor in pathophysiological functions of phagocytic leukocytes. Pathol Int. 2007;57:1-11.
8. Jager E, Jager D, Knuth A. CTL-defined cancer vaccines: perspectives for active immunotherapeutic interventions in minimal residual disease. Cancer Metastasis Rev. 1999;18:143-150.
9. Chen Z, Moyana T, Saxena A, et al. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. Int J Cancer. 2001; 93:539-548.
10. + T-cell immunity against B16 melanoma. J Immunol. 2003;171:5940-5947.
11. Hayashi T, Nakao K, Nagayama Y, et al. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models. Int J Oncol. 2005;26:1313-1319.
12. Gonzalez VM, Fuertes MA, Alonso C, et al. Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol. 2001;59:657-663.
13. Choi BK, Choi CH, Oh HL, et al. Role of ERK activation in cisplatin-induced apoptosis in A172 human glioma cells. Neurotoxicology. 2004;25:915-924.
14. Etoh T, Takahashi H, Maie M, et al. Tumor imaging by antineuroblastoma monoclonal antibody and its application to treatment. Cancer. 1988;62:1282-1286.
15. Calder CJ, Nicholson LB, Dick AD. A selective role for the TNF p55 receptor in autocrine signaling following IFN-gamma stimulation in experimental autoimmune uveoretinitis. J Immunol. 2005;175:6286-6293.
16. Hume DA, Ross IL, Himes SR, et al. The mononuclear phagocyte system revisited. J Leukoc Biol. 2002;72:621-627.
17. Erbacher A, Gieseke F, Handgretinger R, et al. Dendritic cells: functional aspects of glycosylation and lectins. Hum Immunol. 2009;70:308-312.
18. Kondoh N, Schweinfest CW, Henderson KW, et al. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res. 1992;52:791-796.
19. Suzuki K, Olvera J, Wool IG. The primary structure of rat ribosomal protein S19. Biochimie. 1990;72:299-302. (Pubitemid 20176054)
20. Yamamoto T. Molecular mechanism of monocyte predominant infiltration in chronic inflammation: mediation by a novel monocyte chemotactic factor, S19 ribosomal protein dimer. Pathol Int. 2000;50:863-871.
21. Lauber K, Blumenthal SG, Waibel M, et al. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell. 2004;14: 277-287.
22. Elliott MR, Chekeni FB, Trampont PC, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 2009;461:282-286.
23. Munoz LE, Peter C, Herrmann M, et al. Scent of dying cells: the role of attraction signals in the clearance of apoptotic cells and its immunological consequences. Autoimmun Rev. 2010;9: 425-430.
24. Tesniere A, Apetoh L, Ghiringhelli F, et al. Immunogenic cancer cell death: a key-lock paradigm. Curr Opin Immunol. 2008;20:504-511.
25. Tesniere A, Schlemmer F, Boige V, et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 2010;29:482-491.
26. Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13:1050-1059.